Yassmine Akkari

8.6k total citations · 2 hit papers
49 papers, 2.7k citations indexed

About

Yassmine Akkari is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Yassmine Akkari has authored 49 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Genetics and 14 papers in Cancer Research. Recurrent topics in Yassmine Akkari's work include DNA Repair Mechanisms (17 papers), Genomic variations and chromosomal abnormalities (11 papers) and Prenatal Screening and Diagnostics (9 papers). Yassmine Akkari is often cited by papers focused on DNA Repair Mechanisms (17 papers), Genomic variations and chromosomal abnormalities (11 papers) and Prenatal Screening and Diagnostics (9 papers). Yassmine Akkari collaborates with scholars based in United States, Canada and United Kingdom. Yassmine Akkari's co-authors include Susan B. Olson, Markus Grompe, Milton J. Finegold, Holger Willenbring, Mark P. Foster, Yumi Torimaru, Muhsen Al-Dhalimy, Xin Wang, Eric Lagasse and Carol Reifsteck and has published in prestigious journals such as Nature, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Yassmine Akkari

48 papers receiving 2.6k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell fusion is the principal source of bone-marrow-derived hepatocytes

2003 1.2k citations Yassmine Akkari, Yumi Torimaru et al. profile →
Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)

2022 101 citations Yassmine Akkari, Robert G. Best et al. Genetics in Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yassmine Akkari United States	19	1.5k	836	703	577	430	49	2.7k
Jill Williamson United Kingdom	15	1.2k 0.8×	550 0.7×	386 0.5×	442 0.8×	176 0.4×	19	2.1k
Yumi Torimaru United States	6	708 0.5×	653 0.8×	554 0.8×	427 0.7×	100 0.2×	7	1.4k
Mariana D. Dabeva United States	23	881 0.6×	1.7k 2.0×	341 0.5×	1.7k 3.0×	130 0.3×	33	2.7k
Abha Khanna United States	12	764 0.5×	504 0.6×	366 0.5×	219 0.4×	402 0.9×	28	1.8k
Linda J. Osborne United States	11	919 0.6×	918 1.1×	961 1.4×	624 1.1×	55 0.1×	15	2.1k
Raphaël Lis United States	18	978 0.7×	369 0.4×	145 0.2×	289 0.5×	176 0.4×	34	2.0k
Martin Erdel Austria	24	1.3k 0.8×	431 0.5×	195 0.3×	46 0.1×	364 0.8×	72	2.3k
Jason Ross United States	12	1.8k 1.2×	294 0.4×	818 1.2×	96 0.2×	301 0.7×	18	3.9k
Fumie Hosoda Japan	32	2.0k 1.4×	1.3k 1.5×	107 0.2×	166 0.3×	746 1.7×	53	3.6k
Nathalie A. Lokker United States	20	1.1k 0.7×	256 0.3×	328 0.5×	447 0.8×	247 0.6×	29	2.1k

Countries citing papers authored by Yassmine Akkari

Since Specialization

Citations

This map shows the geographic impact of Yassmine Akkari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yassmine Akkari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yassmine Akkari more than expected).

Fields of papers citing papers by Yassmine Akkari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yassmine Akkari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yassmine Akkari. The network helps show where Yassmine Akkari may publish in the future.

Co-authorship network of co-authors of Yassmine Akkari

This figure shows the co-authorship network connecting the top 25 collaborators of Yassmine Akkari. A scholar is included among the top collaborators of Yassmine Akkari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yassmine Akkari. Yassmine Akkari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Church, Alanna J., Yassmine Akkari, Kristin K. Deeb, et al.. (2024). Section E6.7-6.12 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in solid tumors. Genetics in Medicine. 26(4). 101070–101070. 2 indexed citations

Koboldt, Daniel C., Hui Mei, Ying‐Chen Claire Hou, et al.. (2024). Clinically significant findings in a decade‐long retrospective study of prenatal chromosomal microarray testing. Molecular Genetics & Genomic Medicine. 12(3). e2349–e2349. 3 indexed citations

Macke, Erica L., Anthony R. Miller, M. Isabel González, et al.. (2024). Optical Genome Mapping (OGM) Identifies Multiple Structural Variants in a Case With Atypical Phelan‐McDermid Syndrome. American Journal of Medical Genetics Part A. 197(3). e63929–e63929. 1 indexed citations

Akkari, Yassmine, et al.. (2024). Section E6.1–6.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes. Genetics in Medicine. 26(4). 101054–101054. 1 indexed citations

Akkari, Yassmine, et al.. (2024). Optical Genome Mapping in Prenatal Diagnosis: Democratizing Comprehensive Cytogenomic Testing. Clinical Chemistry. 70(6). 783–785. 1 indexed citations

Akkari, Yassmine, Sheila M. Dobin, Robert G. Best, & Marco L. Leung. (2023). Exploring current challenges in the technologist workforce of clinical genomics laboratories. SHILAP Revista de lepidopterología. 1(1). 100806–100806. 6 indexed citations

Levy, Brynn, Linda B. Baughn, Yassmine Akkari, et al.. (2022). Optical genome mapping in acute myeloid leukemia: a multicenter evaluation. Blood Advances. 7(7). 1297–1307. 65 indexed citations

Akkari, Yassmine, Linda B. Baughn, Adrian M. Dubuc, et al.. (2022). Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood. 139(15). 2273–2284. 47 indexed citations

Shao, Lina, Yassmine Akkari, Linda D. Cooley, et al.. (2021). Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 23(10). 1818–1829. 28 indexed citations

10.

Akkari, Yassmine, Hélène Bruyèrè, R. Tanner Hagelstrom, et al.. (2020). Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia. Cancer Genetics. 243. 52–72. 14 indexed citations

11.

Larson, Daniel P., Yassmine Akkari, Daniel L. Van Dyke, et al.. (2020). Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee. Archives of Pathology & Laboratory Medicine. 145(2). 176–190. 3 indexed citations

12.

Rope, Alan F., Tia L. Kauffman, Laura M. Amendola, et al.. (2018). A case for expanding carrier testing to include actionable X‐linked disorders. Clinical Case Reports. 6(11). 2092–2095. 2 indexed citations

13.

Cherry, Athena M., Yassmine Akkari, Hutton M. Kearney, et al.. (2017). Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 19(8). 845–850. 29 indexed citations

14.

Newell, Amy E. Hanlon, et al.. (2008). Loss of homologous recombination or non-homologous end-joining leads to radial formation following DNA interstrand crosslink damage. Cytogenetic and Genome Research. 121(3-4). 174–180. 18 indexed citations

15.

Pejović, Tanja, Hong Yan Liu, Laura E. Hays, et al.. (2006). Cytogenetic Instability in Ovarian Epithelial Cells from Women at Risk of Ovarian Cancer. Cancer Research. 66(18). 9017–9025. 36 indexed citations

16.

Taniguchi, Toshiyasu, Barbara Cox, Yassmine Akkari, et al.. (2006). Natural gene therapy in monozygotic twins with Fanconi anemia. Blood. 107(8). 3084–3090. 61 indexed citations

17.

Maslen, Cheryl L., et al.. (2006). CRELD2: Gene mapping, alternate splicing, and comparative genomic identification of the promoter region. Gene. 382. 111–120. 13 indexed citations

18.

Houghtaling, Scott, et al.. (2005). Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining. Human Molecular Genetics. 14(20). 3027–3033. 42 indexed citations

19.

Akkari, Yassmine, et al.. (2005). Y chromosome heterochromatin of differing lengths in two cell populations of the same individual. Prenatal Diagnosis. 25(4). 304–306. 5 indexed citations

20.

Bruun, Donald A., et al.. (2003). siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells. DNA repair. 2(9). 1007–1013. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact